Skip to main content

Table 1 Combination molar ratios for taxanes, tamoxifen and fulvestrant

From: The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells

Drugs

MCF-7

ZR75-1

 

Ratio

Ratio

Tamoxifen : Paclitaxel

5:3

4:3

Tamoxifen : Docetaxel

5:3

4:3

Fulvestrant : Paclitaxel

5:4

1:1

Fulvestrant : Docetaxel

5:4

1:1